Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2010
09/29/2010EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
09/29/2010EP1421074B1 Novel compounds
09/29/2010EP1095274B1 Trifunctional reagent for conjugation to a biomolecule
09/29/2010CN1947754B Medicine for treating infantile asthma and its preparation method
09/29/2010CN1934077B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
09/29/2010CN1872139B Drop pills for treating bronchitis
09/29/2010CN1810777B Compound for preventing and treating bacterial infection and its preparation and use
09/29/2010CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof
09/29/2010CN101849006A Improved antibody molecule
09/29/2010CN101848900A Crystalline hydrate of betamimetika and use as medicament thereof
09/29/2010CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/29/2010CN101845385A Health-care wine and preparation method thereof
09/29/2010CN101843895A Cytokine receptor ZCYTOR17 multimers
09/29/2010CN101843894A Application of pumpkin protein to preparation of medicament for treating lung cancer
09/29/2010CN101843874A Chinese medicament for treating emphysema
09/29/2010CN101843863A Chinese medicine compound containing bear bile bulbus fritilariae and preparation method thereof
09/29/2010CN101843861A Chinese medicinal composition for treating tonsillitis
09/29/2010CN101843860A Chinese medicament for treating children cold
09/29/2010CN101843845A Chinese medicinal inflammation-dispelling mixture for treating chronic pharyngitis and preparation method thereof
09/29/2010CN101843844A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843840A Chinese medicinal compound granules for treating acute exacerbation of chronic obstructive pulmonary disease
09/29/2010CN101843830A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843829A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843823A Anti-flu injection and preparation method thereof
09/29/2010CN101843797A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843796A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843736A Chinese medicament for treating asthma
09/29/2010CN101843732A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843719A Chinese medicament for treating pulmonary heart diseases
09/29/2010CN101843713A Chinese medicament for treating asthma
09/29/2010CN101843682A Maxingshigan injecta and preparation method thereof
09/29/2010CN101843675A Chinese medicament for treating allergic rhinitis and acute/chronic rhinitis, and preparation process thereof
09/29/2010CN101843667A Shuanghuanglian medicinal composition and preparation method thereof
09/29/2010CN101843659A Traditional Chinese medicine granular formulation for preventing and treating influenza and preparation method thereof
09/29/2010CN101843653A Processing method of Chinese stellera root condensed decoction
09/29/2010CN101843650A Quality control method for effective part of vaccinium vitis-idaea L for treating respiratory system disease
09/29/2010CN101843638A Method for extracting horny substance liquid by using animal horns or hooves and equipment thereof
09/29/2010CN101843631A Application of baicalin in resisting and preventing bacterial infection
09/29/2010CN101843625A Compound ofloxacin injection for livestock and preparation method thereof
09/29/2010CN101843616A Composition of fexofenadine hydrochloride and microcrystalline cellulose and preparation method thereof
09/29/2010CN101843612A Application of isoorientin in preparation of medicament for resisting respiratory syncytial virus
09/29/2010CN101843586A Water-soluble micro powder containing florfenicol and preparation method thereof
09/29/2010CN101401807B Uses of selective JAK3 restrainer VI in antiviral mediated acute lung damnification
09/29/2010CN101337062B Traditional Chinese medicine composition for treating tonsillitis
09/29/2010CN101332254B Traditional Chinese medicine composition for preventing and treating poultry respiratory disease
09/29/2010CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease
09/29/2010CN101313891B Palmatine injection and preparation method thereof
09/29/2010CN101274931B Preparing process for rupatadine
09/29/2010CN101259177B Medicaments for treating chronic bronchitis and confecting method thereof
09/29/2010CN101249131B Gynostemma pentaphylla effective ingredient extract
09/29/2010CN101234182B Bamboo juice composition and preparation and application thereof
09/29/2010CN101234168B Compound angelica sinensis preparations and preparation and application
09/29/2010CN101181478B Chinese medicine for curing lung cancer and mammary cancer
09/29/2010CN101163484B The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
09/29/2010CN101129346B Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same
09/29/2010CN101099864B Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis
09/29/2010CN101099863B Method for preparing triple inactivated vaccine for preventing chicken Newcastle disease, infectious bronchitis and egg drop syndrome
09/29/2010CN101085986B SARS coronavirus disturbance RNA and its uses
09/29/2010CN101036719B Sirup agent for curing cough for children and the preparing method
09/29/2010CN101006087B Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
09/28/2010USRE41783 Pyrrolo[2,3-D]pyrimidine compounds
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents
09/28/2010US7803799 such as 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-5-(selenophen-2-yl)-1H-pyrazole-3-carboxamide, used for treating cannabinoid-receptor mediated disorders selected from obesity, metabolic syndrome, drug abuse and dependence or neuropathic pain
09/28/2010US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
09/28/2010US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
09/28/2010US7802376 Apparatus for treating particulate material
09/28/2010CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
09/28/2010CA2479640C Hfa suspension formulations containing an anticholinergic
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/23/2010WO2010107958A1 RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107957A2 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107952A2 RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106495A1 Sceletium extract and uses thereof
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010106016A1 Pyrimidine derivatives used as itk inhibitors
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010US20100240761 Bronchodilating beta-agonist compositions and methods
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240736 Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240728 Co-Crystals of Pyrrolidinones
09/23/2010US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
09/23/2010US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists
09/23/2010US20100240685 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
09/23/2010US20100240680 Purine derivatives as a2a agonists
09/23/2010US20100240678 Leukotriene b4 inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240629 Polymorphs of fluticasone furoate and processes for preparation thereof
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7